Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2009
DOI: 10.1590/s0100-39842009000400015
|View full text |Cite
|
Sign up to set email alerts
|

Doença de Erdheim-Chester: relato de dois casos

Abstract: A doença de Erdheim-Chester é uma rara histiocitose de células não-Langerhans, de etiologia desconhecida, que apresenta manifestações sistêmicas, atingindo ossos, sistema nervoso central, olhos, pulmões, mediastino, rins e retroperitônio. Relatamos dois casos que cursaram com a apresentação típica da doença. Os achados radiológicos foram concordantes com a literatura e orientaram a suspeita diagnóstica, confirmada pelo exame imuno-histoquímico.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…A variable degree of fibrosis is present and can be predominant, resulting in misinterpretation of the lesion as a reactive fibroinflammatory process. However, other histological patterns have also been described [ 4 , 15 , 18 20 ]. In the current case, fibrous tissue with prominent histiocytes, plasma cells and lymphocytic infiltrate was present.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A variable degree of fibrosis is present and can be predominant, resulting in misinterpretation of the lesion as a reactive fibroinflammatory process. However, other histological patterns have also been described [ 4 , 15 , 18 20 ]. In the current case, fibrous tissue with prominent histiocytes, plasma cells and lymphocytic infiltrate was present.…”
Section: Discussionmentioning
confidence: 99%
“…Immunohistochemistry showed positivity for CD68. Indeed, at immunohistochemistry, ECD samples show positivity for histiocytic markers such as CD68 and CD163 and negativity for CD1a and CD207, thus differentiating ECD from LCH [ 18 20 ]. In the case described here, molecular testing for BRAF V600E was performed, with results being negative.…”
Section: Discussionmentioning
confidence: 99%